Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Aging Clin Exp Res ; 25(3): 265-74, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23784725

RESUMEN

BACKGROUND AND AIMS: Ascertainment bias (AB) indicates a bias of an evaluation centre in estimating the prevalence/incidence of a disease due to the specific expertise of the centre. The aim of our study was to evaluate classification of different types of dementia in new cases appearing in secondary and tertiary centres, in order to evidence possible occurrence of AB in the various (secondary to tertiary) dementia centres. METHODS: To assess the mechanism of AB, the rates of new cases of the different forms of dementia reported by different centres were compared. The centres involved in the study were 11 hospital-based centres including a tertiary centre, located in the University Department of Clinical Neurology. The tertiary centre is endowed with state-of-the-art diagnostic facilities and its scientific production is prominently focused on dementia with Lewy bodies (DLB) thus suggesting the possible occurrence of a bias. Four main categories of dementia were identified: Alzheimer's disease (AD), DLB, fronto-temporal dementia (FTD), vascular dementia (VaD), with other forms in a category apart. The classification rate of new cases of dementia in the tertiary centre was compared with rates reported by secondary centres and rates of recoding were calculated during a follow-up of 2 years. RESULTS: The study classified 2,042 newly diagnosed cases of dementia in a population of 1,370,000 inhabitants of which 315,000 were older than 65. AD was categorized in 48-52 % of cases, DLB in 25-28 %, FTD in 2-4 % and VaD in 17-28 %. During the 2-year follow-up the diagnosis was re-classified in 40 patients (3 %). The rate of recoding was 5 % in the tertiary centre, 2-8 % in referrals from secondary to tertiary centre, 2-10 % in recodings performed in secondary centres and addressed to tertiary centre. Recoding or percentages of new cases of AD or DLB were not different in the comparison between secondary or between secondary and tertiary centres. FTD and VaD were instead significantly recoded. CONCLUSION: The results of the study suggest that in a homogeneous area, AB is not interfering with diagnosis of AD or DLB.


Asunto(s)
Sesgo , Competencia Clínica , Demencia/diagnóstico , Demencia/epidemiología , Hospitales/estadística & datos numéricos , Centros de Atención Terciaria/estadística & datos numéricos , Enfermedad de Alzheimer/diagnóstico , Enfermedad de Alzheimer/epidemiología , Demencia/clasificación , Diagnóstico Diferencial , Demencia Frontotemporal/diagnóstico , Demencia Frontotemporal/epidemiología , Humanos , Italia/epidemiología , Enfermedad por Cuerpos de Lewy/diagnóstico , Enfermedad por Cuerpos de Lewy/epidemiología , Imagen por Resonancia Magnética , Prevalencia , Estudios Retrospectivos , Tomografía Computarizada por Rayos X
2.
Drugs Exp Clin Res ; 15(9): 435-46, 1989.
Artículo en Inglés | MEDLINE | ID: mdl-2630254

RESUMEN

Systemic administration of L-acetylcarnitine HCl (LAC) increases in human subjects the amplitude of visual evoked potentials (VEPs) obtained with patterned elements of 7.5 min of visual angle, of steady-state VEPs obtained with intermittent luminous stimulation, of EEG theta, alpha and beta bands. The latency of the "cognitive" P300 potential obtained with an auditory "oddball" paradigm was also reduced by LAC injection, while the amplitude of this potential was increased. These results were obtained in control volunteers and in patients affected by different forms of dementias. The modifications induced by LAC appear 10-15 min after the i.v. injection and last for 50-90 min. These results parallel previously described findings of animal experiments and suggest an effect of LAC on cholinergic neurotransmission.


Asunto(s)
Acetilcarnitina/efectos adversos , Carnitina/análogos & derivados , Electroencefalografía , Potenciales Evocados Visuales/efectos de los fármacos , Acetilcarnitina/uso terapéutico , Adulto , Anciano , Intoxicación Alcohólica , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/fisiopatología , Carnitina/farmacología , Potenciales Evocados Auditivos/efectos de los fármacos , Femenino , Humanos , Masculino , Memoria/efectos de los fármacos , Persona de Mediana Edad , Sistema Nervioso Parasimpático/efectos de los fármacos , Psicosis Inducidas por Sustancias/tratamiento farmacológico , Psicosis Inducidas por Sustancias/psicología
3.
Riv Neurol ; 58(6): 223-30, 1988.
Artículo en Italiano | MEDLINE | ID: mdl-3150126

RESUMEN

A double blind cross over trial of Sodium Valproate (Na VPA) vs Magnesium Valproate (Mg VPA) was performed in 122 patients affected by focal or generalized epilepsies. Only modest differences resulted from the comparison between the two drugs: retention was 8% superior in patients treated with Mg VPA, the number of critic episodes and the quantification of interictal events was significantly lower in patients affected by focal epilepsy treated with Mg VPA. The incidence of side effects was the same for the two drugs.


Asunto(s)
Epilepsia/tratamiento farmacológico , Ácido Valproico/uso terapéutico , Adolescente , Adulto , Niño , Ensayos Clínicos como Asunto , Método Doble Ciego , Evaluación de Medicamentos , Electroencefalografía , Epilepsia/fisiopatología , Femenino , Humanos , Masculino , Distribución Aleatoria
4.
Minerva Med ; 78(18): 1397-8, 1987 Sep 30.
Artículo en Italiano | MEDLINE | ID: mdl-3658213

RESUMEN

A subacute cerebellar degeneration-like paraneoplastic syndrome is reported in a woman with cystoadenopapillar carcinoma involving both ovaries. This syndrome, characterized by remarkable cerebellar ataxia, is an exceptional disorder which pathogenesis is still unknown although there is a hypothesis of a viral infection and autoimmunitary unchaining.


Asunto(s)
Ataxia Cerebelosa/etiología , Cistoadenoma/complicaciones , Neoplasias Ováricas/complicaciones , Síndromes Paraneoplásicos/etiología , Femenino , Humanos , Persona de Mediana Edad
5.
Minerva Med ; 78(17): 1321-3, 1987 Sep 15.
Artículo en Italiano | MEDLINE | ID: mdl-3670684

RESUMEN

A case of hepatolenticular degeneration with the clinical pattern of Westphal-Strumpell disease is described. Diagnosis was based on clinical pattern, absence of hepatic impairment, typical biochemical abnormalities of copper metabolism and response (clinical and biochemical) to D-penicillamine.


Asunto(s)
Degeneración Hepatolenticular/diagnóstico , Adulto , Cobre/metabolismo , Femenino , Degeneración Hepatolenticular/tratamiento farmacológico , Degeneración Hepatolenticular/metabolismo , Humanos , Penicilamina/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...